Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030

icon1
USD 85.09 BN
MARKET SIZE, 2030
icon2
CAGR 12.6%
(2025-2030)
icon3
560
REPORT PAGES
icon4
671
MARKET TABLES

OVERVIEW

genomics-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, registering a CAGR of 12.6% from 2025 to 2030. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.

KEY TAKEAWAYS

  • BY REGION
    In 2024, North America accounted for the largest share of 40.9% of the genomics market. The development of personalized medicine, the presence of key players in the market, and the increasing incidence of chronic diseases are some factors supporting the growth of the North American genomics market.
  • BY OFFERING
    By offering, the products segment accounted for the largest share of 74% of the genomics market in 2024. This dominance can primarily be attributed to the growing focus of researchers on genome sequencing projects and the increased demand for genomic products in the market.
  • BY TECHNOLOGY
    By technology, the sequencing segment is expected to register the highest CAGR of the genomic products market, due to its vital role in advancements in genetic research, diagnostics, and personalized medicine. Sequencing technologies, such as next-generation sequencing (NGS) and long-read sequencing, have transformed our ability to decode entire genomes. These technologies provide unmatched speed, accuracy, and depth of analysis.
  • BY APPLICATION
    By application, the drug discovery & development segment dominates the genomics market with a share of 44.8%. The large share is due to the growing demand for personalized therapeutics, as genomics-driven drug discovery continues to gain traction, reinforcing its substantial share in the application segment.
  • COMPETITIVE LANDSCAPE
    Illumina, Inc., Thermo Fisher Scientific Inc., and Danaher Corporation were identified as Star players in the genomics market, as they have focused on innovation and have broad industry coverage and strong operational & financial strength. Creative Biogene, Novogene Co., Ltd., and Helix, Inc. have distinguished themselves among startups and SMEs due to their strong product portfolio and business strategy.

The genomics market is experiencing steady growth, driven by advancements in next-generation sequencing (NGS) and the expanding applications of precision medicine and diagnostics. Additionally, there is an increasing amount of government and private funding for genomic research. The rising prevalence of genetic and chronic diseases, along with the integration of artificial intelligence (AI) and bioinformatics for data interpretation, is further driving market adoption across research, clinical, and pharmaceutical sectors.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The genomics market is being transformed by rapid technological advancements, including AI-driven data analysis, cloud-based bioinformatics, and automated sequencing workflows. Emerging trends, such as long-read sequencing, single-cell sequencing, and multi-omics integration, are improving data accuracy and providing deeper biological insights. As a result, pharmaceutical and biotech companies, along with research organizations, are increasingly adopting data-centric and scalable genomic solutions to enhance efficiency, drive innovation, and improve clinical outcomes.

genomics-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing government funding for genomics projects
  • Increasing prevalence of viral and inherited disorders
RESTRAINTS
Impact
Level
  • High investments
OPPORTUNITIES
Impact
Level
  • Increasing use of genomics in precision medicine
  • Technological advancements in genomics
CHALLENGES
Impact
Level
  • Handling of large volumes of data sets and their analysis
  • Clinical utility of genomics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing prevalence of viral and inherited disorders

The increasing prevalence of viral and inherited disorders is a major factor driving the growth of the genomics market. Genomic technologies, such as next-generation sequencing (NGS) and long-read sequencing, can quickly and accurately identify genetic mutations and viral pathogens. This capability aids in the early diagnosis and management of conditions like cystic fibrosis and sickle-cell anemia, among others. Furthermore, identifying mutations at the molecular level for targeted therapies has led to a heightened demand for genomics-based diagnostic tools.

Restraint: High investments

The implementation of advanced technologies, such as next-generation sequencing, long-read sequencing, and gene-editing tools like CRISPR, requires substantial capital investment, which can pose significant constraints. Establishing a genomics facility demands high capital expenditures for specialized instruments, reagents, and bioinformatics infrastructure. Many sequencing platforms and most high-throughput instruments are capital-intensive, resulting in substantial long-term operational costs for maintenance, calibration, and upgrades. These high costs can make it prohibitively expensive for smaller research institutions, healthcare facilities, and companies, thereby limiting widespread adoption of these technologies.

Opportunity: Increasing use of genomics in precision medicine

The increasing use of genomics in precision medicine represents a significant growth opportunity in the genomics market. Precision medicine tailors medical treatment to the individual characteristics of each patient and relies heavily on genomics to analyze genetic variations that influence patients' risks, disease progressions, and treatment responses. By utilizing data from genomics, therapy can be personalized, resulting in improved patient outcomes and reduced reliance on traditional treatments that can be hit-or-miss. The most prominent applications of this approach are found in oncology, where genomics is used to identify cancer-causing mutations that inform targeted therapy selection.

Challenge: Handling of large volumes of data sets and their analysis

One of the main challenges in handling large-scale data volumes and their analysis significantly impacts the genomics market. Next-generation sequencing (NGS) and similar technologies used in genomic applications can generate hundreds of gigabytes to several terabytes of data in just one experiment, particularly in large projects such as whole-genome sequencing and population genomics. The sheer volume of generated data creates issues with storage, processing, and interpretation, necessitating substantial computational infrastructure and specialized bioinformatics tools. As a result, there is a growing demand for high-performance computing (HPC) systems that can efficiently manage and process these large datasets.

genomics-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Nationwide clinical whole-genome sequencing for rare disease and cancer via the 100,000 Genomes Project, running an end-to-end pipeline, from hospital sampling through analysis, using Illumina high-throughput sequencers for data generation. 18.5% of participants’ data produced actionable findings | Foundation for NHS Genomic Medicine Service
Adoption of Illumina DRAGEN secondary analysis in the hospital’s clinical genomics pipeline. Faster secondary analysis and streamlined clinical reporting from DRAGEN’s accelerated variant calling | Improved efficiency for hospital genomics workflows
Used QIAGEN Ingenuity Pathway Analysis (IPA) to mine multi-omics data and identify a novel biomarker that predicts which ovarian cancer patients are likely to respond to standard chemotherapy. Enabled patient stratification and response prediction, informing treatment decisions | Accelerated discovery by leveraging IPA’s curated pathways/knowledge base

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem analysis of the genomics market provides a thorough understanding of the interconnected network of stakeholders, resources, and interactions that shape the industry's dynamics. This ecosystem includes a variety of entities involved in the development, manufacturing, distribution, and utilization of genomics technologies. Key participants include technology developers, suppliers of consumables, service providers, and end users such as research institutions, clinical laboratories, and biotechnology companies. Additionally, regulatory authorities and standards organizations play crucial roles in influencing market trends, driving innovation, and ensuring the ethical use of genomic data.

genomics-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

genomics-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Genomic Products Market, By Type

In 2024, the reagents, kits, and consumables segment held the largest share of the genomics products market, owing to their essential role in sample preparation, library construction, amplification, and sequencing. These products are critical for generating accurate and reproducible genomic data and are required on a recurring basis in both research and diagnostics. The increasing use of NGS and PCR applications, combined with the growth of genomics research and clinical applications, continues to create a strong demand for high-quality reagents and consumables.

Genomic Products Market, By Technology

In 2024, the sequencing segment held the largest share of the genomic products market. This dominance is driven by continuous advances in next-generation sequencing (NGS) technologies, which offer high accuracy, scalability, and cost efficiency. Growing applications in precision medicine, biomarker discovery, and clinical diagnostics, along with the integration of AI-driven data analysis, further drive its widespread adoption and market leadership.

Genomic Products Market, By End User

In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the genomics products market. This can be attributed to the shift from traditional genomic testing methods to cost-effective and more sensitive techniques, such as whole-exome sequencing. Moreover, a wide range of applications, including genetic research, clinical diagnostics, and personalized medicine, drive the segment growth.

Genomic Services Market, By Type

In 2024, the genomic profiling and sequencing services segment held the largest share of the genomic services market. This dominance is driven by continuous advancements in next-generation sequencing (NGS), long-read sequencing, and other high-throughput platforms that have significantly enhanced sequencing speed, accuracy, and cost efficiency. These technological improvements have expanded the accessibility of sequencing services, facilitating their widespread adoption across both research and clinical applications.

Genomics Market, By Study Type

The functional genomics segment accounted for the largest share of the genomics market in 2024. This dominance is driven by its critical role in drug discovery, personalized medicine, and disease mechanism research. The increasing emphasis on translating genomic information into therapeutic insights and identifying gene functions and interactions has further elevated the importance of functional genomics. As research continues to shift toward precision and targeted therapies, demand for functional genomics is expected to rise steadily across both academic and clinical settings.

Genomics Market, By Application

The Diagnostic segment is expected to grow at the fastest rate during the forecast period in the genomics market. In diagnostics, genomics helps identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders. The use of genomics in diagnostics is expected to grow as new applications are added.

REGION

Asia Pacific to be fastest-growing region in global genomics market during forecast period

The Asia Pacific genomics market is expected to register the highest CAGR during the forecast period, driven by rising investments in life science research, expanding healthcare infrastructures, and the growing adoption of precision medicine across key countries such as China, Japan, and India. Government initiatives supporting national genome projects, coupled with increasing collaborations between global and regional players, are accelerating technology transfer and local innovation. Additionally, a large patient base for genetic and chronic diseases is further fueling the demand for genomics-based diagnostics and research in the region.

genomics-market Region

genomics-market: COMPANY EVALUATION MATRIX

In the genomics market matrix, Thermo Fisher Scientific Inc. (Star) leads with a strong market share and a comprehensive product portfolio that spans sequencing platforms, consumables, reagents, and analytical tools. Its broad global presence, continuous product innovation, and strategic collaborations have strengthened its leadership in enabling advanced genomic research and clinical applications. Oxford Nanopore Technologies Plc. (Emerging Leader) is gaining prominence through its novel nanopore sequencing technology, offering scalable and real-time genomic analysis solutions. Oxford Nanopore Technologies shows strong potential to move toward the leaders’ quadrant as the adoption of portable and rapid sequencing platforms continues to accelerate globally.

genomics-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 44.52 Billion
Market Forecast in 2030 (Value) USD 85.09 Billion
Growth Rate CAGR of 12.6% from 2025–2030
Years Considered 2023–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Products
    • Services
  • Products by Type:
    • Reagents
    • Kits
    • and Consumables; Instruments; Bioinformatics Tools
  • Products by Technology:
    • Sequencing
    • PCR
    • Gene Editing
    • Flow Cytometry
    • Microarrays
    • In Situ Hybridization
    • Other Technologies
  • Products by End User:
    • Hospitals
    • Diagnostic Laboratories
    • and Clinics; Academic & Research Institutes; Pharmaceutical & Biotechnology Companies; CROs
    • Other End Users
  • Services by Type:
    • Genomic Profiling and Sequencing Services
    • Sample Preparation and Library Preparation Services
    • Bioinformatics Service
  • Application:
    • Drug Discovery & Development
    • Diagnostics
    • Agriculture and Animal Research
    • Other Applications
  • Study Type:
    • Functional Genomics
    • Biomarker Discovery
    • Pathway Analysis
    • Epigenomics
    • Other Study Types
  • End User by Services:
    • Hospitals
    • Diagnostic Laboratories
    • and Clinics
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: genomics-market REPORT CONTENT GUIDE

genomics-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Europe Genomics Market
  • Country-level market estimation & forecast of the European genomics market
  • Market growth trends analysis
  • Detailed company profiles of competitors
  • Enables prioritized market entry/expansion
  • Helps to anticipate demand
South Korea Gene Editing Market The diagnostics segment is expected to grow at the fastest rate during the forecast period in the genomics market. In diagnostics, genomics helps identify chromosomal disorders, dysmorphic syndromes, teratogenic disorders, and single-gene disorders. The use of genomics in diagnostics is expected to grow as new applications are added Supports localization strategy, partnership development, and identification of high-growth segments in South Korea

RECENT DEVELOPMENTS

  • October 2025 : 10x Genomics, Inc. launched the next generation of its Flex assay, designed for automation-compatible, plate-based multiplexing. The new assay enables scalable single-cell analysis for applications such as functional genomics, CRISPR screens, and FFPE-based translational studies.
  • May 2025 : QIAGEN signed a definitive agreement to acquire Genoox, an AI-driven software provider supporting large-scale genetic test analysis. The acquisition adds Genoox’s cloud-based Franklin platform to the QIAGEN Digital Insights portfolio, enhancing its capabilities in clinical genomics data interpretation.
  • February 2025 : Roche introduced its proprietary Sequencing by Expansion (SBX) technology, a novel approach in next-generation sequencing. The SBX chemistry, integrated with an advanced sensor module, enables ultra-rapid, high-throughput sequencing with enhanced flexibility and scalability across diverse applications.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
15
EXECUTIVE SUMMARY
20
PREMIUM INSIGHTS
25
MARKET OVERVIEW
30
INDUSTRY TRENDS
35
  • 5.1 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTE
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.2 MACROECONOMICS INDICATORS
    TRENDS IN HEALTHCARE SPENDING
    GDP TRENDS AND FORECAST
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF OFFERING, BY KEY PLAYERS, 2022-2024
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022-2024
  • 5.6 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 CASE STUDY ANALYSIS
  • 5.10 IMPACT OF 2025 US TARIFF- GENOMICS MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - US
    - EUROPE
    - ASIA PACIFIC
    IMPACT ON END USER
    - ACADEMIC AND RESEARCH INSTITUTES
    - HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS
50
  • 6.1 KEY EMERGING TECHNOLOGIES
  • 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.3 ADJACENT TECHNOLOGIES
  • 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.5 PATENT ANALYSIS
  • 6.6 FUTURE APPLICATIONS
  • 6.7 IMPACT OF AI/GEN AI ON THE GENOMICS MARKET
    CASE STUDIES OF AI IMPLEMENTATION IN THE GENOMICS MARKET
    INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
SUSTAINABILITY AND REGULATORY LANDSCAPE
70
  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    INDUSTRY STANDARDS
  • 7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
90
  • 8.1 DECISION-MAKING PROCESS
  • 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
  • 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 8.4 MARKET PROFITABILITY
GENOMICS MARKET, BY OFFERING, 2023-2030 (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
110
  • 9.1 INTRODUCTION
  • 9.2 PRODUCTS
  • 9.3 SERVICES
GENOMICS MARKET, BY PRODUCT TYPE, 2023-2030 (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
130
  • 10.1 INTRODUCTION
  • 10.2 REAGENTS, KITS, AND CONSUMABLES
  • 10.3 INSTRUMENTS
  • 10.4 BIOINFORMATICS TOOLS
GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023-2030 (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
200
  • 11.1 INTRODUCTION
  • 11.2 SEQUENCING
  • 11.3 PCR
  • 11.4 GENE EDITING
  • 11.5 FLOW CYTOMETRY
  • 11.6 MICROARRAYS
  • 11.7 IN SITU HYBRIDIZATION
  • 11.8 OTHER TECHNOLOGIES
GENOMICS PRODUCTS MARKET, BY END USER, 2023-2030 (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
210
  • 12.1 DRUG DISCOVERY
  • 12.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
  • 12.3 ACADEMIC AND RESEARCH INSTITUTES
  • 12.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 12.5 CROS
  • 12.6 OTHER END USERS
GENOMICS MARKET, BY SERVICE TYPE, 2023-2030 (USD MILLION)
220
  • 13.1 INTRODUCTION
  • 13.2 GENOMIC PROFILING AND SEQUENCING SERVICES
  • 13.3 SAMPLE PREPARATION AND LIBRARY PREPARATION SERVICES
  • 13.4 BIOINFORMATICS SERVICES
GENOMICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
230
  • 14.1 INTRODUCTION
  • 14.2 DRUG DISCOVERY AND DEVELOPMENT
  • 14.3 DIAGNOSTICS
  • 14.4 AGRICULTURE AND ANIMAL RESEARCH
  • 14.5 OTHER APPLICATIONS
GENOMICS MARKET, BY STUDY TYPE, 2023-2030 (USD MILLION)
250
  • 15.1 INTRODUCTION
  • 15.2 FUNCTIONAL GENOMICS
  • 15.3 BIOMARKER DISCOVERY
  • 15.4 PATHWAY ANALYSIS
  • 15.5 EPIGENOMICS
  • 15.6 OTHER STUDY TYPES
GENOMICS SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
270
  • 16.1 INTRODUCTION
  • 16.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS
  • 16.3 ACADEMIC AND RESEARCH INSTITUTES
  • 16.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 16.5 OTHER END USERS
  • 16.6 INTRODUCTION
  • 16.7 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 16.8 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    UK
    FRANCE
    ITALY
    SPAIN
    REST OF EUROPE
  • 16.9 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    JAPAN
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA PACIFIC
  • 16.10 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 16.11 MIDDLE EAST
    MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST
    GCC COUNTRIES
  • 16.12 AFRICA
    MACROECONOMIC OUTLOOK FOR AFRICA
COMPETITIVE LANDSCAPE
300
  • 17.1 OVERVIEW
  • 17.2 KEY PLAYER COMPETITIVE STRATEGIES/ RIGHT TO WIN
  • 17.3 REVENUE ANALYSIS, 2022-2024
  • 17.4 MARKET SHARE ANALYSIS, 2024
  • 17.5 BRAND/ PRODUCT COMPARISION
  • 17.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - OFFERING FOOTPRINT
    - APPLICATION FOOTPRINT
    - TECHNOLOGY FOOTPRINT
  • 17.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 17.8 COMPETITIVE SCENARIO
    DEALS
    OTHER DEVELOPMENTS
  • 17.9 COMPANY VALUATION AND FINANCIAL METRICS
COMPANY PROFILES
350
  • 18.1 KEY PLAYERS
    ILLUMINA, INC.
    THERMO FISHER SCIENTIFIC INC.
    F. HOFFMANN-LA ROCHE
    DANAHER CORPORATION
    QIAGEN
    AGILENT TECHNOLOGIES
    REVVITY
    BIO-RAD LABORATORIES, INC.
    EUROFINS SCIENTIFIC
    - PACIFIC BIOSCIENCES
    - OXFORD NANOPORE TECHNOLOGIES
    - TAKARA BIO
    - BGI GROUP
    - EPPENDORF AG
    - MERCK KGAA
    - BD
    - ABBOTT LABORATORIES
    - 10X GENOMICS
    - NEW ENGLAND BIOLABS
    - PROMEGA CORPORATION
    - LABORATORY CORPORATION OF AMERICA HOLDINGS
    - IQVIA INC.
    - CHARLES RIVER LABORATORIES
  • 18.2 OTHER PLAYERS
    CREATIVE BIOGENE
    NOVOGENE
    HELIX OPCO
    PHALANX BIOTECH GROUP
    POLARIS GENOMICS
RESEARCH METHODOLOGY
330
  • 19.1 RESEARCH DATA
    SECONDARY DATA
    - Key Sources Of Secondary Data
    - Key Objectives Of Secondary Research
    PRIMARY DATA
    - Breakdown of Primaries
  • 19.2 MARKET SIZE ESTIMATION
    GLOBAL MARKET SIZE ESTIMATION, 2024
    - Company Revenue Analysis (Bottom-Up Approach)
    - Marketsandmarkets Repository Analysis
    - Primary Research
    SEGMENTAL MARKET SIZE ESTIMATION (TOP-DOWN APPROACH)
  • 19.3 MARKET GROWTH RATE PROJECTIONS
    IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • 19.4 DATA TRIANGULATION
  • 19.5 RESEARCH ASSUMPTIONS
APPENDIX
350
  • 20.1 DISCUSSION GUIDE
  • 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 20.3 CUSTOMIZATION OPTIONS
  • 20.4 RELATED REPORTS
  • 20.5 AUTHOR DETAILS

Methodology

This research study utilized extensive secondary sources, directories, and databases to identify and collect valuable information for analyzing the global genomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was primarily used to identify and collect information for the comprehensive, technical, market-oriented, and commercial study of the genomics market. The secondary sources used for this study include Nucleic Acids Research, Genome Biology, the International Journal of Genomics, the National Human Genome Research Institute (NHGRI), the International Chromosome and Genome Society (ICGS), Genome Canada, the European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, the Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), Nature Reviews Genetics, Nature Methods, the Biotechnology and Biological Sciences Research Council (BBSRC), the Organisation for Economic Co-operation and Development (OECD), Genome Research, the National Cancer Institute (NCI), the European Medicines Agency (EMA), the Population Health Research Institute (PHRI), PubMed, World Bank, the World Health Organization (WHO), Eurostat, and Factiva; research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also utilized to gather key information about major players, market classification, and segmentation, as well as industry trends, regional/country-level markets, market developments, and technological perspectives.

Primary Research

After acquiring foundational knowledge about the global genomics market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

These interviews spanned six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Genomics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

After determining the overall market size through the estimation process, the total market was divided into several segments and subsegments.

Genomics Market : Top-Down and Bottom-Up Approach

Genomics Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Genomics is a branch of molecular biology that involves the study of the structure, function, evolution, and mapping of genomes. It applies the techniques of genetics, molecular biology, and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of a selected organism for analysis. Genomics is widely used in diagnostics, drug discovery and development, animal and agricultural research, forensics, and aquaculture research, among others.

Key Stakeholders

  • Genomics Equipment and Consumable Manufacturing Companies
  • Genomics Instrument/System Manufacturing Companies
  • Suppliers and Distributors of Genomic Instruments/Systems, Consumables, and Services
  • Hospitals, Diagnostic Centers, and Medical Colleges
  • Research Institutes
  • Hospitals and Academic Medical Centers (AMCs)
  • Government Bodies/Municipal Corporations
  • Business Research Firms
  • Venture Capitalists
  • Pharmaceutical and Biopharmaceutical Companies

Report Objectives

  • To define, describe, and forecast the genomics market based on offering, product type, service type, product by technology, application, end user by product, end user by service, and region, in terms of value
  • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
  • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall genomics market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key players in the genomics market and comprehensively analyze their product and service portfolios, market positions, and core competencies
  • To track and analyze competitive developments in the genomics market, such as acquisitions, product & service launches, expansions, agreements, partnerships, and collaborations
  • To benchmark players within the genomics market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product & service portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific genomics market into countries
  • A further breakdown of the Rest of Europe genomics market into countries
  • A further breakdown of the Rest of Latin America genomics market into countries
  • A further breakdown of the Rest of Middle East genomics market into countries

 

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Genomics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Genomics Market

Nathan

Dec, 2022

I am looking for detailed market size valuation pointers for the Genomics Market from 2025 to 2030. Is this data included in your study?.

Andy

Dec, 2022

Can you elaborate more on the global growth dynamics of the Genomics Market?.

Edward

Oct, 2022

Which are the major building blocks for the global growth of Genomics Market?.

Lucas

Oct, 2022

Which of the geographical segment holds the major share of the Genomics Market?.

DMCA.com Protection Status